Literature DB >> 2487071

The pharmacokinetics of the biliary excretion of ciprofloxacin.

C S Ball1, J M Manson, F Reid, D E Tweedle.   

Abstract

The pharmacokinetics of ciprofloxacin excretion have been studied in 54 patients undergoing biliary and pancreatic operations with and without obstruction of the common bile duct. High concentrations were achieved in common duct bile within 20 minutes of intravenous injection and persisted for over 3 hours after 100 mg and for over 8 hours after 200 mg. The concentration of ciprofloxacin in the bile of functioning gall bladders was much greater than that in the common duct bile. Remarkably, it was identified in therapeutic concentrations in the bile of obstructed ducts. This and the rapid fall from initially high venous concentrations probably reflect diffusion from the circulation as a result of the exceptional tissue penetration. A unique feature of this study was the finding of clinically significant concentrations in the bile of obstructed ducts. Two patients developed wound infection and no side effects were observed. The broad spectrum antibiotic ciprofloxacin has potential as a useful agent for prophylaxis in biliary surgery maintaining biliary and venous concentrations in excess of the MIC90 for most biliary pathogens for more than 8 hours.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487071      PMCID: PMC2423548          DOI: 10.1155/1989/41415

Source DB:  PubMed          Journal:  HPB Surg        ISSN: 0894-8569


  3 in total

Review 1.  New developments and concepts in antimicrobial therapy for intra-abdominal infections.

Authors:  Z Younes; D A Johnson
Journal:  Curr Gastroenterol Rep       Date:  2000-08

2.  Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract.

Authors:  S J van den Hazel; X H de Vries; P Speelman; J Dankert; G N Tytgat; K Huibregtse; D J van Leeuwen
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

3.  Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model.

Authors:  L Kuepfer; C Niederalt; T Wendl; J-F Schlender; S Willmann; J Lippert; M Block; T Eissing; D Teutonico
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.